Sea Sponge-Derived Drug, Fights Advanced Breast Cancer
Filed in archive Drugs, Vaccines and Therapeutics , Other Biotechnology News on June 6, 2010
Eribulin - a chemotherapy drug derived from sea sponge - has been found to extend the lives of women with metastatic breast cancer by about 2.5 months.
According to study author Dr. Christopher Twelves, who is a professor of clinical cancer pharmacology and oncology and head of the Clinical Cancer Research Groups at the Leeds Institute of Molecular Medicine and St. James' Institute of Oncology in Leeds, U.K.:
"We have a major need for new therapies. We see a statistically significant benefit in overall survival in a situation where we rarely see this sort of improvement. Eribulin targets the . . . mechanisms by which the cells divide, which is different from previous agents."
The above finding was presented on Sunday at the annual meeting of the American Society of Clinical Oncology in Chicago.
Tags: Eribulin, chemotherapy drug from sea sponge, metastatic breast cancer biotech breast+cancer
Vote for Sea Sponge-Derived Drug, Fights Advanced Breast Cancer:
|
Rating: 8.20 out of 5 vote(s) cast.
|
| RSS |  |
 | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Follow us on Twitter! |
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells